AAB Medical Technologist (MT) Hematology Practice Exam 2026 – All-in-One Guide to Exam Success!

Idiopathic thrombocytopenic purpura (ITP) is characterized by increased platelet destruction. In this condition, the immune system mistakenly targets and destroys platelets, leading to a decrease in their number. This autoimmune response is often linked to the presence of antibodies that specifically bind to platelets, marking them for destruction by the spleen and other components of the immune system.

What is critical in ITP is not merely a low platelet count but the underlying mechanism that causes the reduction. Unlike conditions where the body may produce an increased number of platelets to compensate for loss or destruction, ITP features a predominance of destruction rather than a production issue.

Additionally, while the platelet function may remain normal in many cases of ITP, the significant aspect that defines the disorder is the increase in destruction leading to thrombocytopenia, which is why this option aligns with the pathophysiology of ITP. Understanding this mechanism is important for diagnosing and managing the condition effectively.